Unexpected T-cell reactions to adenoviral COVID-19 vaccines discovered

FHS
July 20, 2024
1:15 am

Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.

J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition – Pharmaceutical Technology

NM26 is designed to inhibit the interleukin (IL)-4R and IL-31 cytokine pathways. Credits: Michael Vi/Shutterstock.com Johnson & Johnson (J&J) has announced that it has completed

July 11, 2024

Controversial Gene Therapy Wins FDA Approval for Duchenne Muscular Dystrophy

The FDA granted accelerated approval to delandistrogene moxeparvovec (Elevidys), the first gene therapy for Duchenne muscular dystrophy, the agency announced Thursday. The adeno-associated virus-based gene

June 23, 2023

Vegetarian diet linked to lower risk of insomnia, study suggests

Study reveals that following a vegetarian diet may reduce the risk of insomnia, particularly in men, potentially due to higher intakes of healthful plant-based foods

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.